Rocket Lab Shares Gain Momentum Amid SpaceX IPO Speculation

Rocket Lab shares gain as SpaceX IPO talk revalues the sector. The company posts record Q4 revenue of $179.65M and a $1.85B backlog, despite recent insider sales.

Speculation surrounding a potential initial public offering for SpaceX is generating significant interest across the space sector. As investors anticipate the market debut of the industry leader, established competitor Rocket Lab USA is attracting considerable attention. The company is benefiting from the broader industry enthusiasm while simultaneously reinforcing its market standing with concrete, record-breaking financial results.

Strong Fundamentals Underpin Recent Gains

Beyond the general sector excitement, Rocket Lab’s recent share price appreciation is supported by robust fundamentals. For the fourth quarter of fiscal 2025, the company reported record revenue of $179.65 million, representing a 36% increase compared to the same period last year. Management has provided an optimistic outlook, guiding for first-quarter 2026 revenue between $185 million and $200 million.

A key driver of this performance is a backlog that has grown to $1.85 billion. This expansion stems primarily from new contracts for satellite systems and an increased launch cadence for its Electron launch vehicle, which recently completed its 85th mission.

Sector-Wide Revaluation Triggered by SpaceX

Reports of a prepared SpaceX IPO are acting as a catalyst for the entire industry. Analysts suggest the private space firm could target a valuation of approximately $1.75 trillion. This staggering figure is prompting investors to reassess the market capitalization of operationally mature competitors like Rocket Lab. With a current market valuation of about $32.5 billion, Rocket Lab is increasingly viewed as a primary alternative for reliable launch services. This sector-wide revaluation contributed to the stock’s advance of over six percent on Tuesday, closing at $64.22.

Analyst Upgrades and a Note of Caution

The combination of strong quarterly figures and the positive sentiment spillover from SpaceX has drawn analyst commentary. Several investment banks have recently raised their price targets for Rocket Lab shares:

• Bank of America: $120
• Morgan Stanley: $105
• Clear Street: $88 (initiated coverage with a "Buy" rating)

Despite this positive analyst sentiment, recent insider sales of approximately 1.8 million shares over past weeks advise a degree of caution. The year-to-date performance also presents a mixed picture; since the start of 2026, the stock has lost about 15% of its value, highlighting the ongoing volatility characteristic of the space sector.

Strategic Diversification Efforts

Rocket Lab is actively pursuing diversification to reduce its reliance on commercial rocket launches. A recently secured $190 million contract with the U.S. Department of Defense for suborbital test missions bolsters its defense business. Concurrently, a $23.9 million award under the CHIPS and Science Act is funding the expansion of semiconductor manufacturing. This initiative aims to increase production of space-grade solar cells by 50% over the next three years, positioning the company to meet growing demand from large satellite constellations.